CVRx, Inc. - Common Stock, $0.01 par value (CVRX)

CUSIP: 126638105

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 7 signals
Share change
+596,776
Put/Call ratio
0%
SEC-reported price per share
$5.14
Number of holders
86
Value change
-$2,978,577
Number of buys
41
Open additional details 1 more signal available
Number of sells
44
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
26,612,903

Security key

126638105

Report period

Q2 2026

Institutions

86

Top holders

10

Ownership snapshot

Top reported holders of CVRX - CVRx, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
JOHNSON & JOHNSON
Disclosed value leader
Johnson & Johnson Innovat...
Comparable rows
4/15
Latest evidence
01 Jun 2026
3/4/5 13D/G 13F Lead comparable stake: 15% 11 rows are not safely comparable across share classes. 13D/G row: JOHNSON & JOHNSON Showing 1-6 of 15 holder rows.

Quick read

JOHNSON & JOHNSON leads the comparable SEC ownership view at 15%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens JOHNSON & JOHNSON's linked filing trail.
Comparable ownership Top 4
JOHNSON & JOHNSON 15%
NEW ENTERPRISE ASSOCIATES 10 L P 7.8%
Vensana Capital I GP, LLC 7.2%
Gilde Healthcare IV U.a. Cooperat... 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
JOHNSON & JOHNSON
3/4/5 13D/G 13F
10%+ Owner · Company
15%
Reported 13D/G · 31 Dec 2025
$40,369,355
4,024,861 shares
-$861,042 26 Nov 2025
NEW ENTERPRISE ASSOCIATES 10 L P
3/4/5 13D/G
10%+ Owner · New Enterprise Associates 10, Limited Partnership
7.8%
Reported 13D/G · 18 Feb 2025
$37,593,767
2,026,083 shares
— 02 Jul 2021
Vensana Capital I GP, LLC
13D/G
Kirk Nielsen
7.2%
Reported 13D/G · 31 Dec 2024
$11,849,740
1,760,734 shares
$0 31 Dec 2024
Gilde Healthcare IV U.a. Cooperatieve
13D/G
Cooperatieve Gilde Healthcare IV U.A.
4.9%
Reported 13D/G · 04 Feb 2025
$8,287,928
1,231,490 shares
$0 04 Feb 2025
Johnson & Johnson Innovation - JJDC, Inc.
3/4/5
10%+ Owner
—
denominator unverified
$64,860,045
3,495,575 shares
— 15 Sep 2023
GSK plc
3/4/5 13F
10%+ Owner · Company
—
denominator unverified
$18,695,602
1,007,583 shares
— 02 Jul 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
86
Shares
15,261,448
Rows available
86
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
98
Q2 2026 holders
86
Holder diff
-12
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .